Northwell Health is fundraising $1B

Northwell Health, a New York-based healthcare provider, has launched a seven-year effort to raise $1 billion that will support innovative initiatives.

The fundraising campaign will advance research and funding for endowment for teaching and research initiatives and support capital projects, and improve hospitals and clinical programs. The campaign, “Outpacing the Impossible,” includes nearly $500 million given by donors since Jan. 1, 2016.

"Philanthropy is critical to Northwell Health," Brian Lally, Northwell's senior vice president and chief development officer, said in a statement. "Our entire health system is focused on the communities we serve. Philanthropy is our investment back into our communities and helps us to take better care of more people."

The healthcare organization noted that the time is right for a large philanthropic effort, as increasing healthcare costs as well as declining and delayed government and insurance reimbursement “creates the perfect storm” for numerous challenges in the area of innovation.

Northwell received more than $177.3 million in philanthropic support in 2017.

"We believe in the power and potential impact of taking on challenges and going where others won't," Northwell Health President and CEO Michael Dowling said in a statement. "Our ambition is to innovate, and it's part of everything we do. We don't settle for the norm in health care, and through the generosity and support of our communities, and each other, we will push our standards even further, for the best care to better the lives of every person we touch."

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.